The Food and Drug Administration authorized for marketing an algorithm-driven medical device for diagnosing a common, but difficult to detect, type of heart failure. . . . → Read More: FDA Clears AI Heart Failure Detection System
|
|||||
       |
A company creating extended-release delivery techniques for eye therapies is raising $11.9 million in its first venture funding round. . . . → Read More: Sustained-Released Eye Treatment Company Raises $11.9M  Comments are closed  Finance, New products  biomedical, biotechnology, chemistry, entrepreneurs, equity, investment, life sciences, materials science, pharmaceuticals, physical sciences, U.K., university, venture capital 
A company discovering therapies with artificial intelligence is partnering with M.D. Anderson Cancer Center on new small-molecule precision medicines. . . . → Read More: Biotech, M.D. Anderson Partner on Precision Drug Design One comment - (Comments are closed) Joint ventures/collaborations, New products biomedical, biotechnology, cancer, chemistry, genomics, life sciences, mathematics, pharmaceuticals, physical sciences, U.K., university 
Research with lab animals shows an experimental cancer vaccine generates immune-system cells that infiltrate solid tumors and reduce the tumor’s protective environment. . . . → Read More: Dual-Action Vaccine Shown to Attack, Shrink Solid Tumors One comment - (Comments are closed) Joint ventures/collaborations, New products biomedical, biotechnology, cancer, chemistry, entrepreneurs, genomics, life sciences, nanotechnology, NIH, pharmaceuticals, physical sciences, preclinical, U.K., university 
Results from a clinical trial show an experimental one-time antibody therapy, even at low doses, lowers levels of HIV virus in people living with the disease. . . . → Read More: Trial Shows Antibody Neutralizes, Reduces HIV Virus Comments are closed New products biomedical, biotechnology, clinical trials, health care, HIV, life sciences, pharmaceuticals, U.K. 
Colorized scanning electron micrograph of a T lymphocyte. (NIAID) 19 Oct. 2022. A biotechnology enterprise discovering new drugs from non-protein coding regions of the genome is raising €37.5 million ($US 36.6 million) in venture funds. Nucleome Therapeutics Ltd. in Oxford, U.K. is a three year-old business spun-off from genetic research labs at University . . . → Read More: “Dark Genome” Drug Discoverer Gains $37M in Early Funds One comment - (Comments are closed) Finance, New products biomedical, biotechnology, entrepreneurs, equity, Europe, genomics, investment, life sciences, mathematics, pharmaceuticals, physical sciences, U.K., university, venture capital 
An analysis of gut bacteria and blood samples from patients indicates changes in the microbiome can provide early warnings for colorectal cancer. . . . → Read More: Gut Microbes Shown to Detect Colorectal Cancer One comment - (Comments are closed) New products biomedical, biotechnology, cancer, clinical trials, Europe, genomics, life sciences, mathematics, medical device, physical sciences, U.K., university 
Two companies agreed to license technologies from academic labs in the U.S. and U.K. for developing faster and more sensitive at-home tests for Covid-19 infections. . . . → Read More: Univ. Labs Ink Licensing Deals for Covid-19 Tests Comments are closed Intellectual property, New products biomedical, biotechnology, chemistry, Covid-19, entrepreneurs, genomics, licensing, life sciences, medical device, physical sciences, U.K., university 
A biotechnology developer of treatments for autoimmune disorders with checkpoint receptor proteins is acquired by drug maker Gilead Sciences. . . . → Read More: Immune Disease Biotech Acquired in $405M Deal One comment - (Comments are closed) Finance, New products biomedical, biotechnology, chemistry, entrepreneurs, equity, investment, life sciences, merger, pharmaceuticals, physical sciences, U.K., university 
Drug maker GSK is buying a biotechnology company developing vaccines for respiratory and infectious diseases that generate multiple immune responses. . . . → Read More: GSK Acquires Advanced Vaccine Biotech in $3.3B Deal Comments are closed Finance, New products biomedical, biotechnology, chemistry, equity, investment, life sciences, merger, pharmaceuticals, physical sciences, U.K. |
||||
|
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts
You must be logged in to post a comment.